Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 7 | 2025 | 292 | 1.660 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2020 | 98 | 1.280 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2020 | 171 | 1.180 |
Why?
|
| Hemostatic Techniques | 1 | 2025 | 12 | 0.940 |
Why?
|
| Hemorrhage | 3 | 2025 | 279 | 0.920 |
Why?
|
| Catheterization, Peripheral | 1 | 2025 | 50 | 0.910 |
Why?
|
| Collagen | 1 | 2025 | 135 | 0.890 |
Why?
|
| Angioplasty, Balloon, Coronary | 7 | 2011 | 171 | 0.820 |
Why?
|
| Electrosurgery | 1 | 2020 | 5 | 0.650 |
Why?
|
| Heart Injuries | 1 | 2020 | 19 | 0.640 |
Why?
|
| Papillary Muscles | 1 | 2020 | 16 | 0.640 |
Why?
|
| Mitral Valve | 2 | 2017 | 126 | 0.600 |
Why?
|
| Cardiac Catheters | 1 | 2017 | 13 | 0.520 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 78 | 0.510 |
Why?
|
| Heart Valve Prosthesis | 1 | 2017 | 106 | 0.470 |
Why?
|
| Stents | 5 | 2017 | 496 | 0.410 |
Why?
|
| Treatment Outcome | 12 | 2025 | 5776 | 0.340 |
Why?
|
| Aortic Coarctation | 1 | 2008 | 12 | 0.290 |
Why?
|
| Equipment Design | 3 | 2025 | 361 | 0.280 |
Why?
|
| Aneurysm, False | 1 | 2008 | 47 | 0.280 |
Why?
|
| Coronary Artery Disease | 2 | 2011 | 322 | 0.270 |
Why?
|
| Heart-Assist Devices | 2 | 2021 | 158 | 0.270 |
Why?
|
| Femoral Artery | 3 | 2013 | 104 | 0.260 |
Why?
|
| Hemostasis | 1 | 2025 | 19 | 0.230 |
Why?
|
| Middle Aged | 18 | 2025 | 18208 | 0.230 |
Why?
|
| Punctures | 1 | 2025 | 62 | 0.230 |
Why?
|
| Percutaneous Coronary Intervention | 3 | 2014 | 223 | 0.220 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2017 | 168 | 0.210 |
Why?
|
| Male | 22 | 2025 | 30953 | 0.210 |
Why?
|
| Aged | 16 | 2020 | 14924 | 0.200 |
Why?
|
| Hemostasis, Surgical | 1 | 2002 | 21 | 0.190 |
Why?
|
| Surgical Stapling | 1 | 2002 | 11 | 0.190 |
Why?
|
| Myocardial Infarction | 5 | 2011 | 918 | 0.180 |
Why?
|
| Device Removal | 2 | 2017 | 64 | 0.180 |
Why?
|
| Humans | 27 | 2025 | 64954 | 0.180 |
Why?
|
| Female | 19 | 2025 | 33927 | 0.180 |
Why?
|
| Radial Artery | 2 | 2013 | 55 | 0.170 |
Why?
|
| Giant Cells | 1 | 2021 | 16 | 0.170 |
Why?
|
| Endovascular Procedures | 2 | 2017 | 626 | 0.160 |
Why?
|
| Myocarditis | 1 | 2021 | 71 | 0.160 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2017 | 117 | 0.150 |
Why?
|
| Heart | 2 | 2021 | 297 | 0.150 |
Why?
|
| Angiography | 3 | 2014 | 154 | 0.130 |
Why?
|
| Stroke Volume | 3 | 2009 | 341 | 0.130 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 25 | 0.130 |
Why?
|
| Foreign-Body Migration | 1 | 2017 | 24 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 1655 | 0.130 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2017 | 44 | 0.130 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 17 | 0.120 |
Why?
|
| Vena Cava, Inferior | 1 | 2016 | 33 | 0.120 |
Why?
|
| Heart Neoplasms | 1 | 2016 | 36 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 112 | 0.120 |
Why?
|
| Nephrectomy | 1 | 2016 | 92 | 0.120 |
Why?
|
| Superior Vena Cava Syndrome | 2 | 2005 | 9 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2017 | 160 | 0.110 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 114 | 0.110 |
Why?
|
| Vascular Closure Devices | 1 | 2014 | 6 | 0.110 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2014 | 26 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 174 | 0.110 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2014 | 23 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2014 | 67 | 0.110 |
Why?
|
| Thrombectomy | 1 | 2016 | 253 | 0.100 |
Why?
|
| Thrombosis | 1 | 2016 | 206 | 0.100 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 111 | 0.100 |
Why?
|
| Hospital Mortality | 4 | 2011 | 873 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 84 | 0.100 |
Why?
|
| Coronary Disease | 2 | 2011 | 246 | 0.090 |
Why?
|
| Patient Safety | 1 | 2014 | 258 | 0.090 |
Why?
|
| Aged, 80 and over | 7 | 2011 | 5601 | 0.090 |
Why?
|
| Time Factors | 5 | 2014 | 3758 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2013 | 222 | 0.080 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 14 | 0.080 |
Why?
|
| Risk Assessment | 4 | 2014 | 2094 | 0.080 |
Why?
|
| Myocardial Revascularization | 1 | 2011 | 78 | 0.080 |
Why?
|
| Defibrillators, Implantable | 2 | 2021 | 273 | 0.080 |
Why?
|
| Risk Factors | 5 | 2014 | 5408 | 0.080 |
Why?
|
| Equipment Safety | 2 | 2014 | 26 | 0.070 |
Why?
|
| Sensation Disorders | 1 | 2008 | 23 | 0.070 |
Why?
|
| Peripheral Arterial Disease | 1 | 2011 | 165 | 0.070 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2008 | 27 | 0.070 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2009 | 69 | 0.070 |
Why?
|
| Systole | 1 | 2008 | 109 | 0.070 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 118 | 0.070 |
Why?
|
| Cerebellum | 1 | 2008 | 94 | 0.070 |
Why?
|
| Postural Balance | 1 | 2008 | 67 | 0.070 |
Why?
|
| Creatinine | 1 | 2007 | 135 | 0.060 |
Why?
|
| Angioplasty | 2 | 2008 | 53 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 414 | 0.060 |
Why?
|
| Retrospective Studies | 8 | 2014 | 6842 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2008 | 251 | 0.060 |
Why?
|
| Registries | 1 | 2011 | 909 | 0.060 |
Why?
|
| Epigastric Arteries | 1 | 2006 | 7 | 0.060 |
Why?
|
| Electrocardiography | 3 | 2021 | 553 | 0.060 |
Why?
|
| Coronary Restenosis | 1 | 2006 | 21 | 0.060 |
Why?
|
| Metabolic Syndrome | 1 | 2007 | 146 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2014 | 3305 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 292 | 0.060 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2005 | 45 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 2005 | 55 | 0.060 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2005 | 67 | 0.060 |
Why?
|
| Catheterization | 1 | 2005 | 111 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 929 | 0.050 |
Why?
|
| Pacemaker, Artificial | 1 | 2005 | 50 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2008 | 418 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 731 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2013 | 2482 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2011 | 1108 | 0.050 |
Why?
|
| Inpatients | 1 | 2005 | 315 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2005 | 276 | 0.050 |
Why?
|
| Massachusetts | 3 | 2014 | 2143 | 0.050 |
Why?
|
| Endocardium | 1 | 2021 | 14 | 0.040 |
Why?
|
| Adult | 5 | 2011 | 17313 | 0.040 |
Why?
|
| Troponin I | 1 | 2021 | 36 | 0.040 |
Why?
|
| Sex Factors | 3 | 2011 | 991 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 58 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2013 | 585 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 106 | 0.040 |
Why?
|
| Biopsy | 1 | 2021 | 454 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2021 | 180 | 0.040 |
Why?
|
| Shock, Cardiogenic | 2 | 2011 | 108 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 380 | 0.040 |
Why?
|
| Stroke | 1 | 2007 | 1208 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2014 | 2614 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1044 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 1476 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 198 | 0.030 |
Why?
|
| Age Factors | 2 | 2011 | 1580 | 0.030 |
Why?
|
| Embolic Protection Devices | 1 | 2014 | 5 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 1439 | 0.030 |
Why?
|
| X-Rays | 1 | 2014 | 46 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 2013 | 13 | 0.030 |
Why?
|
| Drug-Eluting Stents | 1 | 2014 | 68 | 0.030 |
Why?
|
| Propensity Score | 1 | 2014 | 189 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2014 | 194 | 0.020 |
Why?
|
| Heart Rate | 1 | 2014 | 331 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 374 | 0.020 |
Why?
|
| Incidence | 2 | 2006 | 1415 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 309 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 1270 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 1280 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 576 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 555 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1692 | 0.020 |
Why?
|
| Perfusion | 1 | 2008 | 75 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 1775 | 0.020 |
Why?
|
| Transplants | 1 | 2007 | 8 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2007 | 25 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 186 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 29 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 881 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 2006 | 23 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2011 | 463 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2006 | 122 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 1 | 2009 | 252 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2006 | 67 | 0.010 |
Why?
|
| Hematoma | 1 | 2006 | 82 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2013 | 1314 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 663 | 0.010 |
Why?
|
| Length of Stay | 1 | 2009 | 826 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2006 | 210 | 0.010 |
Why?
|
| Phlebography | 1 | 2005 | 45 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2006 | 234 | 0.010 |
Why?
|
| Smoking | 1 | 2007 | 861 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 1214 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 2240 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 4793 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 6293 | 0.010 |
Why?
|
| United States | 1 | 2007 | 8083 | 0.010 |
Why?
|